Literature DB >> 5637056

Fibrinogen-fibrin interaction.

V A Belitser, T V Varetskaja, G V Malneva.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5637056     DOI: 10.1016/0005-2795(68)90051-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  7 in total

1.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

2.  Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitis.

Authors:  J T Wilde; W E Thomas; D A Lane; M Greaves; F E Preston
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

3.  Structure of the fibrin protofibril.

Authors:  W E Fowler; R R Hantgan; J Hermans; H P Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

4.  Fibrinogen Marburg a new genetic variant of fibrinogen.

Authors:  G Fuchs; R Egbring; K Havemann
Journal:  Blut       Date:  1977-02

5.  Localization of a fibrin gamma-chain polymerization site within segment Thr-374 to Glu-396 of human fibrinogen.

Authors:  B H Horwitz; A Váradi; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  Polymerisation and crosslinking of fibrin monomers in diabetes mellitus.

Authors:  A Lütjens; T W Jonkhoff-Slok; C Sandkuijl; E A vd Veen; J vd Meer
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

7.  Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.

Authors:  H R Gralnick; H M Givelber; J R Shainoff; J S Finlayson
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.